UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Annals of oncology, 2012-11, Vol.23 (11), p.2827-2834

2012

Volltextzugriff (PDF)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

Journal of cancer research and clinical oncology, 2020-10, Vol.146 (10), p.2681-2691

2020

Volltextzugriff (PDF)

FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome

Annals of oncology, 2018-06, Vol.29, p.v108-v108

2018

Volltextzugriff (PDF)

mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)

Annals of oncology, 2018-06, Vol.29, p.v108-v108

2018

Volltextzugriff (PDF)

Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510

International journal of cancer, 2022-03, Vol.150 (6), p.1007-1017

2022

Volltextzugriff (PDF)

O-024mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

O-023FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

FOLFOX / Bevacizumab (Beva) +/- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA)

Annals of oncology, 2016-10, Vol.27, p.vi560-vi560

2016

Volltextzugriff (PDF)

RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R‐CHOP, R‐MCP, R‐FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO

Hematological oncology, 2017-06, Vol.35 (S2), p.32-32

2017

Volltextzugriff (PDF)

Randomisierte klinische Studie zu einer Coping Support Intervention für Eltern von Adoleszenten und jungen Erwachsenen (AYA) mit hämatologischen Malignomen

Psychotherapie, Psychosomatik, medizinische Psychologie, 2018-08, Vol.68 (8), p.e17-e17

2018

Volltextzugriff (PDF)

Ifosfamide, epirubicin and granulocyte colony-stimulating factor : A regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

Hematological oncology, 2001-06, Vol.19 (2), p.59-66

2001

Volltextzugriff (PDF)

Perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4053-4053

2011

Volltextzugriff (PDF)

ULCERATIVE BALANOPOSTHITIS AS THE INITIAL MANIFESTATION OF ACUTE PROMYELOCYTIC LEUKEMIA

The Journal of urology, 1998-10, Vol.160 (4), p.1430-1431

1998

Volltextzugriff (PDF)

ATRA-syndrome

Pneumologie (Stuttgart, Germany), 2007-04, Vol.61 (4), p.226

2007

Volltextzugriff (PDF)

Impact of meningeal dissemination (MD) on outcome in primary CNS lymphoma in the G-PCNSL-SG1 trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2026-2026

2011

Volltextzugriff (PDF)

Prognostic factors for response and survival in primary central nervous system lymphoma (PCNSL) from a randomized phase III trial (G-PCNSL-SG-1)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2004-2004

2011

Volltextzugriff (PDF)

Docetaxel, cisplatin, and capecitabine (DCX) as perioperative chemotherapy in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4116-4116

2010

Volltextzugriff (PDF)

Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia

Annals of hematology, 1997-09, Vol.75 (3), p.91-94

1997

Volltextzugriff (PDF)

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

Hematological oncology, 2001-06, Vol.19 (2), p.59-66

2001

Volltextzugriff (PDF)

TRANSPORT OF UNCONTAMINATED AND MOLLUSCICIDE-CONTAINING FOOD IN THE DIGESTIVE TRACT OF THE SLUG DEROCERAS RETICULATUM (MÜLLER)

Journal of molluscan studies, 1993-02, Vol.59 (1), p.35-42

1993

Volltextzugriff (PDF)

Primary Intracranial Manifestation of CD7/CD56-Positive Acute Myelogenous Leukemia

Oncology research and treatment, 2000-12, Vol.23 (6), p.580-582

2000

Volltextzugriff (PDF)

A novel simplified ultra-rapid freezing technique for cryopreservation of tissue slices

Cryobiology, 2006-04, Vol.52 (2), p.193-199

2006

Volltextzugriff (PDF)

Pulmonale und pleurale Manifestationen beim Plasmozytom

TumorDiagnostik & Therapie, 2007-04, Vol.28 (2), p.94-99

2007

Volltextzugriff (PDF)

RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R‐CHOP, R‐MCP, R‐FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO

Hematological oncology, 2017-06, Vol.35, p.32-32

2017

Volltextzugriff (PDF)

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Annals of oncology, 2012-11, Vol.23 (11), p.2827

2012

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(115)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Humans
(42)
Female
(23)
Male
(23)
Middle Aged
(18)
Adult
(15)
Oncology
(14)
Aged
(11)
Neurosciences & Neurology
(11)
Orthopedics
(11)
Neurosciences
(10)
Treatment Outcome
(9)
Biological And Medical Sciences
(8)
Hematology
(8)
Surgery
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Medicine
(7)
Medicine & Public Health
(7)
Prospective Studies
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome

mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)

Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510

O-024mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)

O-023FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome

FOLFOX / Bevacizumab (Beva) +/- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA)

RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R‐CHOP, R‐MCP, R‐FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO

Randomisierte klinische Studie zu einer Coping Support Intervention für Eltern von Adoleszenten und jungen Erwachsenen (AYA) mit hämatologischen Malignomen

Ifosfamide, epirubicin and granulocyte colony-stimulating factor : A regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

Perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

ULCERATIVE BALANOPOSTHITIS AS THE INITIAL MANIFESTATION OF ACUTE PROMYELOCYTIC LEUKEMIA

ATRA-syndrome

Impact of meningeal dissemination (MD) on outcome in primary CNS lymphoma in the G-PCNSL-SG1 trial

Prognostic factors for response and survival in primary central nervous system lymphoma (PCNSL) from a randomized phase III trial (G-PCNSL-SG-1)

Docetaxel, cisplatin, and capecitabine (DCX) as perioperative chemotherapy in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

TRANSPORT OF UNCONTAMINATED AND MOLLUSCICIDE-CONTAINING FOOD IN THE DIGESTIVE TRACT OF THE SLUG DEROCERAS RETICULATUM (MÜLLER)

Primary Intracranial Manifestation of CD7/CD56-Positive Acute Myelogenous Leukemia

A novel simplified ultra-rapid freezing technique for cryopreservation of tissue slices

Pulmonale und pleurale Manifestationen beim Plasmozytom

RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R‐CHOP, R‐MCP, R‐FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Suchergebnisse filtern